NEWS

PRESS RELEASES

04.26.13:
Monoclonal Antibody with Xencor’s High ADCC Fc Technology Enters Phase 2 Study in B-cell Acute Lymphoblastic Leukemia

PUBLICATIONS

03.25.13:

Matthew J. Bernett, Seung Y. Chu, Irene Leung, Gregory L. Moore, Sung-Hyung Lee, Erik Pong, Hsing Chen, Sheryl Phung, Umesh S. Muchhal, Holly M. Horton, Greg A. Lazar, John R. Desjarlais, David E. Szymkowski (2013)

Immune suppression in cynomolgus monkeys by XPro9523: An improved CTLA4-Ig fusion with enhanced binding to CD80, CD86 and neonatal Fc receptor FcRn. Volume 5, Issue 3, May/June 2013, http://dx.doi.org/10.4161/mabs.23976 Abstract The CTLA4-Ig fusion proteins abatacept and belatacept are clinically proven … …

ARTICLES

10 Next-Gen Biologics Platforms: – FierceBiotech

EVENTS

06.12.13 – 06.14.13 CALBIO Summit 2013 (Bassil Dahiyat, Ph.D., presenting; San Diego, CA)